Beta 2-microglobulin-deficient background ameliorates lethal phenotype of the TGF-beta 1 null mouse
- PMID: 10491004
Beta 2-microglobulin-deficient background ameliorates lethal phenotype of the TGF-beta 1 null mouse
Abstract
TGF-beta 1 null (TGF-beta1-/-) mice die at 3-4 wk of age and show an autoimmune inflammatory phenotype associated with enhanced expression of both class I and II MHC molecules. To determine the role of MHC class I Ags in the autoimmune manifestations and the inflammation observed in TGF-beta 1-/- mice, we generated TGF-beta 1-/- mice in the genetic background of beta 2-microglobulin deficiency (beta 2M-/-). TGF-beta 1-/-;beta 2M-/- mice had improved survival compared with TGF-beta 1-/- mice. Histopathological examination showed less severe inflammation, especially in the heart, where Mac-2 reactive macrophages were significantly decreased as compared with TGF-beta 1-/- mice. In vivo depletion of CD8+ T cells in TGF-beta 1-/- mice confirmed suppression of inflammation and reduction in the severity of the wasting syndrome. MHC class II mRNA expression in TGF-beta 1-/-;beta 2M-/- mice was also lower than that in TGF-beta 1-/- mice, suggesting reduced systemic inflammation. Autoimmune response as judged by serum Ab titers to ssDNA and 16/6 Id and by immune complex deposits in kidney was reduced in TGF-beta 1-/-;beta 2M-/- mice, when compared with that in TGF-beta 1-/- mice. Our data thus indicate that MHC class I molecules influence the development of the autoimmunity and the inflammation seen in TGF-beta 1-/- mice and CD8+ T cells may have a contribution to the inflammation in TGF-beta 1-/- mice.
Similar articles
-
Autoimmunity associated with TGF-beta1-deficiency in mice is dependent on MHC class II antigen expression.J Clin Invest. 1996 Nov 1;98(9):2109-19. doi: 10.1172/JCI119017. J Clin Invest. 1996. PMID: 8903331 Free PMC article.
-
Up-regulation of cytokine mRNA, adhesion molecule proteins, and MHC class II proteins in salivary glands of TGF-beta1 knockout mice: MHC class II is a factor in the pathogenesis of TGF-beta1 knockout mice.J Immunol. 1997 Jun 1;158(11):5527-35. J Immunol. 1997. PMID: 9164977
-
TGF-beta1 and IFN-gamma cross-regulate antigen presentation to CD4 T cells by macrophages.J Leukoc Biol. 2002 Jul;72(1):163-6. J Leukoc Biol. 2002. PMID: 12101276
-
Transforming growth factor beta (TGF-beta) and autoimmunity.Autoimmun Rev. 2005 Sep;4(7):450-9. doi: 10.1016/j.autrev.2005.03.006. Autoimmun Rev. 2005. PMID: 16137611 Review.
-
MHC class I-deficient mice.Adv Immunol. 1994;55:381-421. doi: 10.1016/s0065-2776(08)60514-3. Adv Immunol. 1994. PMID: 8304235 Review.
Cited by
-
Elimination of both CD4+ and CD8+ T cells but not B cells eliminates inflammation and prolongs the survival of TGFbeta1-deficient mice.Cell Immunol. 2004 Nov-Dec;232(1-2):96-104. doi: 10.1016/j.cellimm.2005.02.004. Epub 2005 Mar 29. Cell Immunol. 2004. PMID: 15922720 Free PMC article.
-
TGF-β signalling is required for CD4⁺ T cell homeostasis but dispensable for regulatory T cell function.PLoS Biol. 2013 Oct;11(10):e1001674. doi: 10.1371/journal.pbio.1001674. Epub 2013 Oct 8. PLoS Biol. 2013. PMID: 24115907 Free PMC article.
-
Advances and Challenges in Targeting TGF-β Isoforms for Therapeutic Intervention of Cancer: A Mechanism-Based Perspective.Pharmaceuticals (Basel). 2024 Apr 20;17(4):533. doi: 10.3390/ph17040533. Pharmaceuticals (Basel). 2024. PMID: 38675493 Free PMC article. Review.
-
Functional conservation in genes and pathways linking ageing and immunity.Immun Ageing. 2021 May 14;18(1):23. doi: 10.1186/s12979-021-00232-1. Immun Ageing. 2021. PMID: 33990202 Free PMC article. Review.
-
Transforming Growth Factor-β Signaling in Immunity and Cancer.Immunity. 2019 Apr 16;50(4):924-940. doi: 10.1016/j.immuni.2019.03.024. Immunity. 2019. PMID: 30995507 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Molecular Biology Databases
Research Materials